Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1002/phar.2398

http://scihub22266oqcxt.onion/10.1002/phar.2398
suck pdf from google scholar
32259313!7262196!32259313
unlimited free pdf from europmc32259313    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32259313      Pharmacotherapy 2020 ; 40 (5): 416-437
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019 #MMPMID32259313
  • Barlow A; Landolf KM; Barlow B; Yeung SYA; Heavner JJ; Claassen CW; Heavner MS
  • Pharmacotherapy 2020[May]; 40 (5): 416-437 PMID32259313show ga
  • The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID-19) can manifest on a spectrum of illness from mild disease to severe respiratory failure requiring intensive care unit admission. As the incidence continues to rise at a rapid pace, critical care teams are faced with challenging treatment decisions. There is currently no widely accepted standard of care in the pharmacologic management of patients with COVID-19. Urgent identification of potential treatment strategies is a priority. Therapies include novel agents available in clinical trials or through compassionate use, and other drugs, repurposed antiviral and immunomodulating therapies. Many have demonstrated in vitro or in vivo potential against other viruses that are similar to SARS-CoV-2. Critically ill patients with COVID-19 have additional considerations related to adjustments for organ impairment and renal replacement therapies, complex lists of concurrent medications, limitations with drug administration and compatibility, and unique toxicities that should be evaluated when utilizing these therapies. The purpose of this review is to summarize practical considerations for pharmacotherapy in patients with COVID-19, with the intent of serving as a resource for health care providers at the forefront of clinical care during this pandemic.
  • |*Immunomodulation[MESH]
  • |Adenosine Monophosphate/administration & dosage/adverse effects/analogs & derivatives[MESH]
  • |Adrenal Cortex Hormones[MESH]
  • |Alanine/administration & dosage/adverse effects/analogs & derivatives[MESH]
  • |Antibodies, Monoclonal, Humanized/administration & dosage/adverse effects[MESH]
  • |Antiviral Agents/*administration & dosage/*adverse effects[MESH]
  • |Azetidines/administration & dosage/adverse effects[MESH]
  • |Betacoronavirus[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |COVID-19 Serotherapy[MESH]
  • |Chloroquine/administration & dosage/adverse effects[MESH]
  • |Coronavirus Infections/*drug therapy/therapy[MESH]
  • |Drug Combinations[MESH]
  • |Humans[MESH]
  • |Hydroxychloroquine/administration & dosage/adverse effects[MESH]
  • |Immunization, Passive[MESH]
  • |Interferon-alpha/administration & dosage/adverse effects[MESH]
  • |Lopinavir/administration & dosage/adverse effects[MESH]
  • |Nelfinavir/administration & dosage/adverse effects[MESH]
  • |Nitro Compounds[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*drug therapy[MESH]
  • |Purines[MESH]
  • |Pyrazoles[MESH]
  • |Ribavirin/administration & dosage/adverse effects[MESH]
  • |Ritonavir/administration & dosage/adverse effects[MESH]
  • |SARS-CoV-2[MESH]
  • |Sulfonamides/administration & dosage/adverse effects[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box